The fight against cancer has spurred the development of innovative and diverse therapeutic strategies, one of which is oncolytic bacterial therapy. This rapidly emerging field leverages genetically modified bacteria that selectively target and destroy cancer cells while sparing healthy... Read more
Alfa Cytology has recently embarked on a groundbreaking journey by initiating their specialized development services for PARP (Poly ADP-ribose polymerase) inhibitors. This move signifies their unwavering commitment to advancing cancer therapy using cutting-edge treatment methods. As a leading figure in... Read more
Alfa Cytology has revealed new FAP-targeted therapeutics development services that aim to develop precise and effective cancer treatments. Alfa Cytology has introduced its groundbreaking initiative which targets fibroblast activation protein(FAP) for cancer therapies. These solutions focusing on FAP to improve treatment... Read more
Cancer treatment has witnessed transformative advancements over the past few decades, notably with the emergence of CAR-T (Chimeric Antigen Receptor T-cell) therapy. This revolutionary therapy harnesses the body’s immune system by genetically engineering T-cells to target and destroy... Read more